Labor court orders Clalit to give patient medication

Health service made to supply deteriorating patient with medication that could help him, even before an appeals committee reviews his case.

By
November 18, 2010 04:28
1 minute read.
Pills.

Pills 311. (photo credit: Courtesy)

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analysis from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Tel Aviv Labor Court this week ordered Clalit Health Services to at least temporarily supply a 74- year-old man whose condition is declining with a medication that could help him, even before an appeals committee reviews his case.

The suit was filed by lawyer Osnat Robovitz- Barkash in the labor court – the judiciary body that has the authority to deal with cases relating to the basket of health services – by the Dolev Foundation for Medical Justice.

Judge Shmuel Tannenbaum strongly criticized the country’s largest health fund for “footdragging for more than four months” and rejecting his request to appoint an appeals committee.

The patient has a rare neuropathic disease that affects his whole body. Previously, Clalit approved a drug for him that was not registered for this kind of disorder, but it failed. His specialist prescribed another drug also not listed for this specific condition.


The patient, who said the second drug was cheaper than the first, has a low pension income and cannot afford to purchase the drug by himself.

The Dolev Foundation lawyer said the court ruling was a “significant achievement for the public because, for the first time, the labor court recognized the urgency of saving a life” and forced the health fund to approve the treatment immediately, even before the health fund appeal committee bureaucrats discussed the case.

“There is no doubt that his condition requires the health insurer to act quickly,” the lawyer said, adding that it sets a precedent for other desperate patients and will prevent future delays in treatment.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia

By UNIVERSITY OF MICHIGAN HEALTH SYSTEM